** Tilray Inc’s shares up 5.1% at $51.20 in extended trading
** TLRY beats quarterly revenue estimates boosted by legalization of recreational cannabis in Canada, acquisition of hemp-based food producer Manitoba Harvest and expansion in international medical markets
** Pulls up shares of other cannabis cos: U.S.-listed Hexo Corp by 3.6%, Canopy Growth 1.3%, Aurora Cannabis, which reports quarterly results later on Tuesday, 2.3%
** TLRY’s revenue nearly tripled to $23 mln, beating analysts’ estimates of $20.2 mln, according to IBES data from Refinitiv
** TLRY down 34.1% YTD
** Horizons Marijuana Life Sciences ETF up nearly 40% this year, while ETFMG Alternative Harvest ETF up 33.4% (Reporting by Uday Sampath in Bengaluru)
Our Standards: The Thomson Reuters Trust Principles.